RSS-Feed abonnieren

DOI: 10.1055/s-0044-1801834
Glycemic Control of Children and Adolescents with Type 1 Diabetes in the United Arab Emirates: A Narrative Review.
Autor*innen
Funding This work is supported by a Research Training Fees Offset Scholarship from the Australian Government (S.A.).
Abstract
Background Diabetes is the fastest-growing chronic disease in the world with increased morbidity and mortality associated with a diagnosis at a young age. The landscape of glycemic control of children and adolescents in the United Arab Emirates, a dynamic and fast evolving country in the Middle East, is unknown, potentially limiting decisions around patient care, health system planning, and efforts around advocacy.
Aim This article determines the reported glycemic control of this vulnerable population, and factors influencing blood glucose management.
Methods A quantitative epidemiological narrative review was conducted using PubMed, CINAHL, and Cochrane databases, searched from 2012 to 2023. English studies involving the study population were reviewed and appraised.
Results Overall, 16 studies were included, mainly heralding from Abu Dhabi and involving Emirati nationals. Reported mean hemoglobin A1c (HbA1c) ranged from 7.9 to 9.6% (63–81 mmol/mol) and diabetes-related technology use was high. Themes identified were diabetes and technology, education, psychology, and Ramadan.
Conclusion Glycemic control was suboptimal, with mean HbA1c being hyperglycemic across included studies, despite a high use of diabetes-related technology. Unless change is made, children and adolescents and young adults with type 1 diabetes will likely experience unnecessary morbidity and mortality.
Authors' Contributions
All authors played a vital role in the concept, design, gathering of data, analysis, write up, review, and editing of this manuscript. S.A., being the PhD student, was supported by her supervisors with weekly touch points to review every process and provide feedback and editing where needed. A.D. being the endocrinologist was also crucial to this manuscript as her views and insights regarding the data collection and analysis as well as review of the paper as a whole was a significant contributing factor.
Data Availability
Any additional data requested will be made available upon request.
Statement of Conformance to the Declaration of Helsinki
This study was conducted in full compliance with the ethical principles set forth in the Declaration of Helsinki. As the study did not involve human participants or personal data, ethics approval was not required.
Publikationsverlauf
Artikel online veröffentlicht:
20. Januar 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Ogle GD, James S, Dabelea D. et al. Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas. 10th ed. Diabetes Res Clin Pract 2022; 183: 109083
- 2 de Bock M, Codner E, Craig ME. et al. ISPAD Clinical Practice Consensus Guidelines 2022: glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes 2022; 23 (08) 1270-1276
- 3 T1dindex. Searched by country: United Arab Emirates with figures 2023. Accessed October 2, 2024 at: https://www.t1dindex.org/countries/united-arab-emirates/
- 4 The Healthcare system in the United Arab Emirates. Accessed May 5, 2024 at: https://www.expatica.com/ae/healthcare/healthcare-basics/the-healthcare-system-in-the-united-arab-emirates-71767/
- 5 Lee SM, Song I, Suh D, Chang C, Suh DC. Treatment costs and factors associated with glycemic control among patients with diabetes in the United Arab Emirates. J Obes Metab Syndr 2018; 27 (04) 238-247
- 6 Suryawanshi PB, Aher VN. Analyse the various marketing strategies of healthcare insurance companies working in UAE. Int J Profession Stud 2023; 15 (Jan-Jun): 1-8
- 7 Paulo MS, Loney T, Lapão LV. How do we strengthen the health workforce in a rapidly developing high-income country? A case study of Abu Dhabi's health system in the United Arab Emirates. Hum Resour Health 2019; 17 (01) 9
- 8 Centre for Reviews and Dissemination. Systematic Reviews. CRD's guidance for undertaking reviews in health care. In: Centre for Reviews and Dissemination; 2008. Accessed January 2, 2025 at: https://www.york.ac.uk/crd/
- 9 Page MJ, Moher D, Bossuyt PM. et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021; 372 (160) n160
- 10 Alawadi F, Abusnana S, Afandi B. et al. Emirates Diabetes Society consensus guidelines for the management of Type 2 Diabetes Mellitus – 2020. Dubai Diabetes Endocrinol J 2020; 26: 1-20
- 11 Shieb M, Koruturk S, Srivastava A, Mussa BM. Growth of diabetes research in United Arab Emirates: current and future perspectives. Curr Diabetes Rev 2020; 16 (04) 395-401
- 12 Deeb A, Yousef H, Al Qahtani N. et al. Novel ambulatory glucose-sensing technology improves hypoglycemia detection and patient monitoring adherence in children and adolescents with type 1 diabetes. J Diabetes Metab Disord 2019; 18 (01) 1-6
- 13 Almazrouei R, Sharma C, Afandi B. et al. Continuous subcutaneous insulin infusion is associated with a better glycemic control than multiple daily insulin injections without difference in diabetic ketoacidosis and hypoglycemia admissions among Emiratis with Type 1 diabetes. PLoS One 2022; 17 (09) e0264545
- 14 Deeb A, Akle M, Abdulrahman L, Suwaidi H, Awad S, Remeithi S. Using insulin pump with a remote-control system in young patients with diabetes improves glycemic control and enhances patient satisfaction. Clin Diabetes Endocrinol 2019; 5: 7
- 15 Deeb A, Abu-Awad S, Abood S. et al. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus. Diabetes Technol Ther 2015; 17 (03) 166-170
- 16 Deeb A, Qahtani NA, Ali AA, Akle M. Impact of targeted education on managing warning and error signals by children and adolescents with type 1 diabetes using the Accu-Chek Combo Insulin Pump System. Ann Pediatr Endocrinol Metab 2017; 22 (03) 170-175
- 17 Deeb A, Yousef H, Abdelrahman L. et al. Implementation of a diabetes educator care model to reduce paediatric admission for diabetic ketoacidosis. J Diabetes Res 2016; 2016: 3917806
- 18 Deeb A, Abdelrahman L, Tomy M. et al. Impact of insulin injection and infusion routines on lipohypertrophy and glycemic control in children and adults with diabetes. Diabetes Ther 2019; 10 (01) 259-267
- 19 Deeb A, Al Hajeri A, Alhmoudi I, Nagelkerke N. Accurate carbohydrate counting is an important determinant of postprandial glycemia in children and adolescents with type 1 diabetes on insulin pump therapy. J Diabetes Sci Technol 2017; 11 (04) 753-758
- 20 Younes ZMH, Abuali AM, Tabba S, Farooqi MH, Hassoun AAK. Prevalence of diabetes distress and depression and their association with glycemic control in adolescents with type 1 diabetes in Dubai, United Arab Emirates. Pediatr Diabetes 2021; 22 (04) 683-691
- 21 Hussain T, Akle M, Nagelkerke N, Deeb A. Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy. SAGE Open Med 2017; 5: 2050312117694938
- 22 Deeb A, Al Qahtani N, Akle M. et al. Attitude, complications, ability of fasting and glycemic control in fasting Ramadan by children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract 2017; 126: 10-15
- 23 Deeb A, Al Qahtani N, Attia S, Al Suwaidi H, Nagelkerke N. Does reducing basal insulin during Ramadan fasting by children and adolescents with type 1 diabetes decrease the risk of symptomatic hypoglycemia?. Diabetes Technol Ther 2016; 18 (09) 539-542
- 24 Beshyah AS, Beshyah SA. The incidence of diabetic ketoacidosis during Ramadan fasting: a 10-year single-centre retrospective study. Diabetes Res Clin Pract 2019; 150: 296-300
- 25 Kaplan W, Afandi B, Al Hassani N, Hadi S, Zoubeidi T. Comparison of continuous glucose monitoring in adolescents with type 1 diabetes: Ramadan versus non-Ramadan. Diabetes Res Clin Pract 2017; 134: 178-182
- 26 Afandi B, Kaplan W, Al Hassani N, Hadi S, Mohamed A. Correlation between pre-Ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes. J Endocrinol Invest 2017; 40 (07) 741-744
- 27 Muammar T, Fojas EGF, Helal R, Lessan N. Ramadan fasting among older children and adolescents with type 1 diabetes mellitus: a real-world study from the United Arab Emirates. Front Nutr 2022; 9: 786678
- 28 Schulz K, Altman D, Moher D. CONSORT statement: updated guidelines for reporting parallel group randomisation trials. Ann Intern Med 2010; 152: 1-7
- 29 Hassanein M, Afandi B, Yakoob Ahmedani M. et al. Diabetes and Ramadan: practical guidelines 2021. Diabetes Res Clin Pract 2022; 185: 109185
- 30 Foster NC, Beck RW, Miller KM. et al. State of type 1 diabetes management and outcomes from the type 1 diabetes exchange in 2016–2018. Diabetes Technol Ther 2019; 21 (02) 66-72
- 31 James S, Perry L, Lowe J, Harris M, Craig ME. ADDN study group. Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: data from the Australasian Diabetes Data Network registry. Pediatr Diabetes 2022; 23 (06) 736-741
- 32 Saiyed M, Hasnani D, Alonso GT. et al; SWEET study group. Worldwide differences in childhood type 1 diabetes: the SWEET experience. Pediatr Diabetes 2021; 22 (02) 207-214
- 33 Deeb A. Challenges of Diabetes Management in Toddlers. Diabetes Technology and Therapeutics 2017; 19: 7
- 34 International Diabetes Federation (IDF) Diabetes and Ramadan (DAR) Alliance 2021 Guidelines. Accessed January 12, 2024 at: https://www.daralliance.org/daralliance/idf-dar-practical-guidelines-2021/
- 35 Rossiter RC, Cooper JL, Marjei SI, Brownie S. Case-based insights: Arab Muslim mothers' experiences of managing a child newly diagnosed with type 1 diabetes mellitus. SAGE Open Nurs 2019; 5: 2377960819870979
- 36 Moola S, Munn Z, Tufanaru C. et al. Chapter 7: Systematic reviews of etiology and risk. In: Aromataris E, Munn Z. eds. JBI Manual for Evidence Synthesis. JBI; 2020. Accessed January 2, 2025 at: https://synthesismanual.jbi.global
- 37 Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness. In: Aromataris E, Munn Z. ed. JBI Manual for Evidence Synthesis. JBI; 2020. . Accessed January 2, 2025 at: https://synthesismanual.jbi.global
- 38 Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int J Evid-Based Healthc 2015; 13 (03) 147-153
